A strategy to discover inhibitors of O-linked glycosylation

被引:55
|
作者
Gross, Benjamin J. [1 ]
Swoboda, Jonathan G. [1 ]
Walker, Suzanne [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA
关键词
D O I
10.1021/ja078125s
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Protein O-glycosylation is involved in numerous biological processes. Deconvoluting the functions of O-linked glycans requires having glycosyltransferace (Gtf) inhibitors suitable for use in cells. Although high-throughput screening has provided small-molecule inhibitors suitable for dissecting kinase pathways, it has not been applied to discover inhibitors of protein glycosylation due to a lack of suitable assays. Here we describe a general protease-protection assay in which a peptide labeled with a FRET pair is subjected to glycosylation and then treated with a protease that discriminated between glycosylated and non-glycosylated peptides. We show that this approach can be adapted to monitor the activity of O-GlcNAc transferase (OGT), a Gtf involved in intracellular signaling, as well as two O-GalNAc transferases (ppGalNAc T1 and T2), which initiate O-linked mucin-type glycosylation. We have used the strategy to screen 124 226 small molecules against OGT and have discovered several low micromolar inhibitors. It should be possible to use this assay to discover inhibitors for many Gtfs that catalyze O-linked glycosylation, which will enable researchers to assess the potential of non-substrate-based small molecules for dissecting glycosylation pathways in cells.
引用
收藏
页码:440 / +
页数:3
相关论文
共 50 条
  • [21] Investigating the role of O-linked glycosylation in Notch:: A chemical approach
    Valdez, CA
    Eastoak-Siletz, A
    Bertozzi, CR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U262 - U262
  • [22] The chemistry and biology of mucin-type O-linked glycosylation
    Hang, HC
    Bertozzi, CR
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (17) : 5021 - 5034
  • [23] Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation
    Jeffrey R. Erickson
    Laetitia Pereira
    Lianguo Wang
    Guanghui Han
    Amanda Ferguson
    Khanha Dao
    Ronald J. Copeland
    Florin Despa
    Gerald W. Hart
    Crystal M. Ripplinger
    Donald M. Bers
    Nature, 2013, 502 : 372 - 376
  • [24] SIZE HETEROGENEITY OF HUMAN LYMPHOTOXIN IS DUE TO O-LINKED GLYCOSYLATION
    KOFLER, G
    GOTTFRIED, I
    BENJAMIN, D
    TSCHACHLER, E
    LYMPHOKINE AND CYTOKINE RESEARCH, 1992, 11 (01): : 9 - 14
  • [25] Increased O-linked Glycosylation in Diabetic Myocardium of Mice and Human
    Agbortoko, Vahid
    Liu, Yuhong
    Shi, Guangbin
    Usheva, Anny
    Singh, Arun K.
    Sellke, Frank W.
    Feng, Jun
    CIRCULATION RESEARCH, 2018, 123
  • [26] IDENTIFICATION OF THE O-LINKED GLYCOSYLATION SITE OF THE HUMAN TRANSFERRIN RECEPTOR
    HAYES, GR
    ENNS, CA
    LUCAS, JJ
    GLYCOBIOLOGY, 1992, 2 (04) : 355 - 359
  • [27] Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation
    Erickson, Jeffrey R.
    Pereira, Laetitia
    Wang, Lianguo
    Han, Guanghui
    Ferguson, Amanda
    Dao, Khanha
    Copeland, Ronald J.
    Despa, Florin
    Hart, Gerald W.
    Ripplinger, Crystal M.
    Bers, Donald M.
    NATURE, 2013, 502 (7471) : 372 - +
  • [28] O-linked mucin-type glycosylation in breast cancer
    Burchell, Joy M.
    Beatson, Richard
    Graham, Rosalind
    Taylor-Papadimitriou, Joyce
    Tajadura-Ortega, Virginia
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2018, 46 : 779 - 788
  • [29] O-linked protein glycosylation in bacteria: snapshots and current perspectives
    Koomey, Michael
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2019, 56 : 198 - 203
  • [30] Understanding and exploiting changes in O-linked glycosylation in breast cancer
    S Julien
    J Coleman
    G Picco
    R Beatson
    J Taylor-Papadimitriou
    J Burchell
    Breast Cancer Research, 10